Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For ongoing pregnancies:
- People who had been diagnosed with insomnia before becoming pregnant
- People whose pregnancy is still ongoing and the outcome (such as miscarriage or live birth) is not yet known
- People who took a sleep medication called QUVIVIQ at any point during the current pregnancy, or shortly before conception
- People who took other (non-orexin receptor antagonist) sleep medications during pregnancy or shortly before conception
- People who took no sleep medications during pregnancy or shortly before conception
For completed pregnancies:
- People who had been diagnosed with insomnia before becoming pregnant
- People whose pregnancy has already ended
- People who took QUVIVIQ at any point during that pregnancy, or shortly before conception
Who may not be able to join:
For both ongoing and completed pregnancies:
- People who took any other sleep medication in the same class as QUVIVIQ (called orexin receptor antagonists) — including medications sold as BELSOMRA® (suvorexant) or DAYVIGO® (lemborexant), any newly approved medications in this class, or any similar medications taken as part of a separate clinical study — during the relevant pregnancy or shortly before conception
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Clinical Trials Study Director, Idorsia Pharmaceuticals Ltd.
Phone: +1 856 661 37 21
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Major congenital malformations classified according to MACDP
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.